J.P. Morgan Chase CEO Jamie Dimon is in a position to go bargain hunting while his competitors mainly suffer on the sidelines. Here are four possible acquisitions. (more)

The one bright spot in M&A in 2008 are drugmakers, where giant pharmaceutical companies are paying record amounts for biotechs to replenish their pipelines. (more)

Every city has one - a retail thoroughfare that houses the most exclusive stores. Real estate slowdown or not, these luxury corridors are still thriving - for now, at least. (more)